Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0963 per EA under NDC 64380072801. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
800 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380072801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA203244On Market Since
11/10/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1000 (Jan 14, 2026) |
| All-time low | $0.0963 (Jun 17, 2026) |
| 52-week high | $0.1000 |
| 52-week low | $0.0963 |
| Median price | $0.0990 |
| Average price | $0.0988 |
| Largest weekly change | -1.7% (Jun 17, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 21 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Strides Pharma Inc., is $0.0963 per EA (NDC 64380072801), effective Jun 24, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 3.7%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Dec 17, 2025, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0963 (Jun 17, 2026) to a high of $0.1000 (Jan 14, 2026), with a median of $0.0990 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
21 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 800 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 64380072801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification